SEC Form 4 · accession 0001127602-19-003331
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Ross Smith
Officer — Corporate Executive VP & CFO
Period of report
Jan 30, 2019
Accepted (ET)
Feb 1, 2019 · 1:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 30, 2019 | A | 11,402 | $0.00 | A | 18,144 | D | |
| Common Stock | Jan 30, 2019 | F | 3,833 | $119.39 | D | 18,144 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 26, 2016.